doc. MUDr. Alexandr Poprach, Ph.D.
Associate professor, Comprehensive Cancer Care Department
Total number of publications: 145
2019
-
Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients
Cancers, year: 2019, volume: 11, edition: 12, DOI
-
miR-376b and miR-4668 predict therapeutic response to sunitinib in metastatic renal cell carcinoma
Year: 2019, type: Conference abstract
-
MiR-376b-3p Is Associated With Long-term Response to Sunitinib in Metastatic Renal Cell Carcinoma Patients
CANCER GENOMICS & PROTEOMICS, year: 2019, volume: 16, edition: 5, DOI
-
miR-376b-3p jako biomarker odpovědi na léčbu sunitinibem u pacientů s metastatickým karcinomem ledviny.
Year: 2019, type: Conference abstract
-
Oligometastatický karcinom prostaty
Klinická onkologie : casopis Ceské a Slovenské onkologické spolecnosti., year: 2019, volume: 32, edition: 2
-
Sequential therapy with bevacizumab and EGFR inhibitors for metastatic colorectal carcinoma: a national registry-based analysis
CANCER MANAGEMENT AND RESEARCH, year: 2019, volume: 11, edition: 2019, DOI
-
The Predictive Role of Primary Tumour Sidedness in Metastatic Colorectal Cancer Treated With Targeted Agents
Anticancer Research, year: 2019, volume: 39, edition: 10, DOI
-
Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, year: 2019, volume: 37, edition: 4, DOI
2018
-
Candidate MicroRNA Biomarkers of Therapeutic Response to Sunitinib in Metastatic Renal Cell Carcinoma: A Validation Study in Patients with Extremely Good and Poor Response
Anticancer Research, year: 2018, volume: 38, edition: 5, DOI
-
Case report of melanoma metastasizing to the pancreas
Gastroenterologie a Hepatologie, year: 2018